Australian Finance Podcast Three ASX shares for exciting growth: ResMed, GenTrack & Pinnacle
13 snips
Jul 2, 2025 Ryan Newman, Director of Research at The Motley Fool Australia, shares his insights on investing in ASX shares. He reveals how to identify promising companies, spotlighting ResMed's innovations in sleep apnea care. Newman discusses GenTrack’s disruptive solutions for utilities and airports, and explains how Pinnacle effectively manages boutique funds. Tune in to learn about the importance of patience in investing, researching like a pro, and recognizing the right business models for long-term growth.
AI Snips
Chapters
Transcript
Episode notes
* watering Flowers, Not Weeds*
- Ryan Newman shared a personal investing mistake involving doubling down on a falling stock without research.
- He learned to "water your flowers, not your weeds" by not adding to losing investments blindly.
Success Through Patience with WiseTech
- Ryan highlighted his biggest investing success with WiseTech Global through patience amid a short seller attack.
- He emphasized understanding the company thesis rather than reacting to share price drops.
Use Reports and Calls to Research
- To research shares, dive deep into annual reports and presentations over multiple years to understand company evolution.
- Listen to earnings calls and read analyst questions for added insight beyond management narratives.